.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
QuintilesIMS
Novartis
Accenture
Farmers Insurance
Fuji
Cipla
Medtronic
McKinsey
Teva

Generated: June 27, 2017

DrugPatentWatch Database Preview

NEO-DELTA-CORTEF Drug Profile

« Back to Dashboard

Which patents cover Neo-delta-cortef, and when can generic versions of Neo-delta-cortef launch?

Neo-delta-cortef is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in NEO-DELTA-CORTEF is neomycin sulfate; prednisolone acetate. There are eighteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; prednisolone acetate profile page.

Summary for Tradename: NEO-DELTA-CORTEF

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list51
Clinical Trials: see list515
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEO-DELTA-CORTEF at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
NEO-DELTA-CORTEF
neomycin sulfate; prednisolone acetate
SUSPENSION/DROPS;OPHTHALMIC061037-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
NEO-DELTA-CORTEF
neomycin sulfate; prednisolone acetate
OINTMENT;OPHTHALMIC061039-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
NEO-DELTA-CORTEF
neomycin sulfate; prednisolone acetate
OINTMENT;OPHTHALMIC061039-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Fuji
Merck
Cipla
Cerilliant
Cantor Fitzgerald
Harvard Business School
Deloitte
US Army
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot